Effectiveness of MBSR Among School Teachers

• Sponsor: University of Aarhus (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03886363
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 24
• Patients Per Site Per Month: 8.3

Study Details

Study Description

Brief Summary

The aim is to evaluate the effectiveness of Mindfulness-Based Stress Reduction among school teachers in Danish schools on mental weii-being in the teachers and their pupils. The study is a cluster-randomised trial including 150 schools; 200 teachers; 4000 pupils from the five geographical regions in Denmark.

Condition or Disease	Intervention/Treatment	Phase
Stress Reduction; Mental Well-being	Behavioral: MBSR	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 200 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Investigator)
• Primary Purpose: Prevention
• Official Title: Effectiveness of Mindfulness-Based Stress Reduction Among Danish School Teachers
• Actual Study Start Date: Dec 18, 2018
• Anticipated Primary Completion Date: Dec 18, 2020
• Anticipated Study Completion Date: Dec 18, 2020

Arms and Interventions

Arm	Intervention/Treatment
Experimental: MBSR MBSR according to international standards (2.5 hours group session once a week in 8 weeks; a silence retreat day; and 45-60 minutes homework six days a week). Content in accordance with MBSR curriculum.	Behavioral: MBSR; Described previously
No Intervention: Wait-list control Usual practice

Outcome Measures

Primary Outcome Measures

1. Change in perceived stress among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   Perceived Stress Scale

2. Change in resilience among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   Brief Resilience Scale

Secondary Outcome Measures

1. Change in symptoms of anxiety and depression among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   Symptom Check List - 5

2. Change in well-being among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   WHO-5

3. Change in mindfulness among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   Five Facet Mindfulness Questionnaire-15

4. Change in resting state among the school teachers [post MBSR (8 weeks from baseline), 6 and 12 months from baseline]

   Amsterdam Resting State Questionnaire

5. Change in social capital among the pupils spending >5 hours with the teachers [post MBSR (8 weeks from baseline)]

   Questions about social capital

6. Change in strengths and difficulties among the pupils spending >5 hours with the teachers [post MBSR (8 weeks from baseline)]

   Strengths and difficulties questionnaire (SDQ)

7. Change in well-being among the pupils spending >5 hours with the teachers [post MBSR (8 weeks from baseline)]

   WHO-5

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• School teacher at a Danish school that commit to participate in a trial aiming to implement and evaluate the effectiveness of ".b" (a school-based mindfulness programme)

Exclusion Criteria:

• acute treatment-demanding clinical depression or a diagnosis of psychosis or schizophrenia

• abuse of alcohol, drugs, medicine

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Danish Center for Mindfulness	Aarhus		Denmark	8220

Sponsors and Collaborators

• University of Aarhus

Investigators

• Study Director: Lone Fjorback, PhD, Aarhus University, Danish Center for Mindfulness

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University of Aarhus
• ClinicalTrials.gov Identifier: NCT03886363
• Other Study ID Numbers: 05032019
• First Posted: Mar 22, 2019
• Last Update Posted: Mar 22, 2019
• Last Verified: Mar 1, 2019

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Mar 22, 2019